Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk
|
Title: Proactive Strategies to Evaluate and Mitigate Clinical Supply Risk
Date: May 24, 2023
Synopsis
The speech focuses on strategies that build understanding of risk assessment within clinical supply planning, and how studies' protocol requirements, drug characteristics, packaging specifications, and patient compliance concerns, must be identified and addressed in order to mitigate risk for successful clinical supply outcomes.
|
|
| |
 |
Julie Delaneyt
Site Director, Singapore site
Catalent
|
|
|
|
|
Sign up for the editor pick and get articles like this delivered right to your inbox.
